Analysts Set HCA Healthcare, Inc. (NYSE:HCA) Target Price at $465.05

Posted by Brian Himes on Aug 10th, 2026

HCA Healthcare, Inc. (NYSE:HCA – Get Free Report) has received a consensus rating of “Moderate Buy” from the twenty-three research firms that are currently covering the firm, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eight have issued a hold recommendation and fourteen have given a buy recommendation to the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $465.5909.

A number of brokerages recently weighed in on HCA. Barclays lowered their price objective on shares of HCA Healthcare from $402.00 to $387.00 and set an “equal weight” rating for the company in a research report on Monday, July 27th. Wells Fargo & Company upped their target price on HCA Healthcare from $369.00 to $381.00 and gave the company an “equal weight” rating in a report on Monday, August 3rd. Oppenheimer reduced their price objective on HCA Healthcare from $520.00 to $485.00 and set an “outperform” rating for the company in a research report on Monday, July 27th. Royal Bank Of Canada reiterated an “outperform” rating and issued a $435.00 target price on shares of HCA Healthcare in a research note on Monday, July 27th. Finally, Weiss Ratings cut shares of HCA Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a report on Tuesday, June 9th.

Read Our Latest Analysis on HCA Healthcare

HCA Healthcare Stock Performance

NYSE HCA opened at $412.80 on Monday. The company’s 50 day moving average price is $389.00 and its 200 day moving average price is $448.60. HCA Healthcare has a one year low of $353.99 and a one year high of $556.52. The firm has a market capitalization of $89.37 billion, a price-to-earnings ratio of 13.82, a PEG ratio of 1.44 and a beta of 1.10.

HCA Healthcare (NYSE:HCA – Get Free Report) last released its quarterly earnings results on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $7.56 by $0.03. HCA Healthcare had a net margin of 8.77% and a negative return on equity of 244.79%. The firm had revenue of $20.23 billion for the quarter, compared to the consensus estimate of $19.76 billion. During the same quarter in the previous year, the firm posted $6.84 EPS. The firm’s quarterly revenue was up 8.7% on a year-over-year basis. Sell-side analysts forecast that HCA Healthcare will post 29.45 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be issued a $0.78 dividend. The ex-dividend date is Wednesday, September 16th. This represents a $3.12 annualized dividend and a dividend yield of 0.8%. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Institutional Trading of HCA Healthcare

Several institutional investors have recently modified their holdings of HCA. Palisade Asset Management LLC acquired a new position in HCA Healthcare during the third quarter worth about $26,000. MidFirst Bank acquired a new position in shares of HCA Healthcare in the 2nd quarter worth approximately $28,000. Clearstead Trust LLC acquired a new stake in HCA Healthcare during the second quarter valued at approximately $29,000. Ares Financial Consulting LLC bought a new position in shares of HCA Healthcare in the fourth quarter valued at $31,000. Finally, Cedar Mountain Advisors LLC bought a new stake in shares of HCA Healthcare during the 1st quarter worth $33,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Company Profile

(Get Free Report)

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.